Literature DB >> 28073755

Advanced Boolean modeling of biological networks applied to systems pharmacology.

Itziar Irurzun-Arana, José Martín Pastor, Iñaki F Trocóniz, José David Gómez-Mantilla.   

Abstract

Motivation: Literature on complex diseases is abundant but not always quantitative. Many molecular pathways are qualitatively well described but this information cannot be used in traditional quantitative mathematical models employed in drug development. Tools for analysis of discrete networks are useful to capture the available information in the literature but have not been efficiently integrated by the pharmaceutical industry. We propose an expansion of the usual analysis of discrete networks that facilitates the identification/validation of therapeutic targets.
Results: In this article, we propose a methodology to perform Boolean modeling of Systems Biology/Pharmacology networks by using SPIDDOR (Systems Pharmacology for effIcient Drug Development On R) R package. The resulting models can be used to analyze the dynamics of signaling networks associated to diseases to predict the pathogenesis mechanisms and identify potential therapeutic targets. Availability and Implementation: The source code is available at https://github.com/SPIDDOR/SPIDDOR . Contact: itzirurzun@alumni.unav.es , itroconiz@unav.es. Supplementary information: Supplementary data are available at Bioinformatics online.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Mesh:

Year:  2017        PMID: 28073755     DOI: 10.1093/bioinformatics/btw747

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  8 in total

Review 1.  Boolean network modeling in systems pharmacology.

Authors:  Peter Bloomingdale; Van Anh Nguyen; Jin Niu; Donald E Mager
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-01-06       Impact factor: 2.745

Review 2.  Boolean modelling as a logic-based dynamic approach in systems medicine.

Authors:  Ahmed Abdelmonem Hemedan; Anna Niarakis; Reinhard Schneider; Marek Ostaszewski
Journal:  Comput Struct Biotechnol J       Date:  2022-06-17       Impact factor: 6.155

3.  A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis.

Authors:  Feiyan Liu; Linda B S Aulin; Sebastiaan S A Kossen; Julius Cathalina; Marlotte Bremmer; Amanda C Foks; Piet H van der Graaf; Matthijs Moerland; Johan G C van Hasselt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-10-19       Impact factor: 2.410

4.  A Middle-Out Modeling Strategy to Extend a Colon Cancer Logical Model Improves Drug Synergy Predictions in Epithelial-Derived Cancer Cell Lines.

Authors:  Eirini Tsirvouli; Vasundra Touré; Barbara Niederdorfer; Miguel Vázquez; Åsmund Flobak; Martin Kuiper
Journal:  Front Mol Biosci       Date:  2020-10-09

5.  A systems pharmacology model for inflammatory bowel disease.

Authors:  Violeta Balbas-Martinez; Leire Ruiz-Cerdá; Itziar Irurzun-Arana; Ignacio González-García; An Vermeulen; José David Gómez-Mantilla; Iñaki F Trocóniz
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 6.  Systems Bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches.

Authors:  Anastasis Oulas; George Minadakis; Margarita Zachariou; Kleitos Sokratous; Marilena M Bourdakou; George M Spyrou
Journal:  Brief Bioinform       Date:  2019-05-21       Impact factor: 11.622

7.  Dynamic Boolean modelling reveals the influence of energy supply on bacterial efflux pump expression.

Authors:  Ryan Kerr; Sara Jabbari; Jessica M A Blair; Iain G Johnston
Journal:  J R Soc Interface       Date:  2022-01-26       Impact factor: 4.118

Review 8.  The greater inflammatory pathway-high clinical potential by innovative predictive, preventive, and personalized medical approach.

Authors:  Greg Gibson; Luigi Manni; Christine Nardini; Maria Giovanna Maturo; Marzia Soligo
Journal:  EPMA J       Date:  2019-12-10       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.